BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29232257)

  • 1. Economics of gynecologic morcellation.
    Bortoletto P; Friedman J; Milad MP
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):89-95. PubMed ID: 29232257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for morcellation in gynecologic surgery.
    Parker WH
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):75-80. PubMed ID: 29251677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and history of morcellators.
    Nezhat C; Zurawin RK
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):65-68. PubMed ID: 29232258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morcellation equipment: past, present, and future.
    Miller CE
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):69-74. PubMed ID: 29194076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morcellation in gynecologic oncology.
    Chalas E
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):96-98. PubMed ID: 29251679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
    Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
    Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in Surgical Practice for Women With Leiomyomas After the U.S. Food and Drug Administration Morcellator Safety Communication.
    Clark NM; Schembri M; Jacoby VL
    Obstet Gynecol; 2017 Nov; 130(5):1057-1063. PubMed ID: 29016511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power morcellation in a specimen bag.
    Cholkeri-Singh A; Miller CE
    J Minim Invasive Gynecol; 2015 Feb; 22(2):160. PubMed ID: 25460317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A medical-legal review of power morcellation in the face of the recent FDA warning and litigation.
    Ton R; Kilic GS; Phelps JY
    J Minim Invasive Gynecol; 2015; 22(4):564-72. PubMed ID: 25623369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
    Parker WH; Pritts EA; Olive DL
    Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of recent power morcellator risk information on inpatient surgery and patient outcomes.
    Schuttringer E; Beleche T
    J Comp Eff Res; 2020 Jan; 9(1):53-65. PubMed ID: 31840551
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease.
    Wright JD; Cui RR; Wang A; Chen L; Tergas AI; Burke WM; Ananth CV; Hou JY; Neugut AI; Temkin SM; Wang YC; Hershman DL
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26449386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Use and Outcomes of Women Undergoing Hysterectomy With Electric Power Morcellation.
    Wright JD; Chen L; Burke WM; Hou JY; Tergas AI; Ananth CV; Hershman DL
    JAMA; 2016 Aug 23-30; 316(8):877-8. PubMed ID: 27552622
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation.
    Lum DA; Sokol ER; Berek JS; Schulkin J; Chen L; McElwain CA; Wright JD
    J Minim Invasive Gynecol; 2016; 23(4):548-56. PubMed ID: 26827905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromechanical morcellators in minimally invasive gynecologic surgery: an update.
    Driessen SR; Arkenbout EA; Thurkow AL; Jansen FW
    J Minim Invasive Gynecol; 2014; 21(3):377-83. PubMed ID: 24462590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Issues with Hysterectomy.
    Barker MA
    Obstet Gynecol Clin North Am; 2016 Sep; 43(3):591-601. PubMed ID: 27521886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of strategies and factors to maximize cost-effectiveness of robotic hysterectomies and myomectomies in benign gynecological disease.
    Wu CZ; Klebanoff JS; Tyan P; Moawad GN
    J Robot Surg; 2019 Oct; 13(5):635-642. PubMed ID: 30919259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicolegal Issues in Power Morcellation: Cautionary Rules for Gynecologists to Avoid Unfavorable Outcomes.
    Zaami S; Zupi E; Lazzeri L; Stark M; Malvasi A; Signore F; Marinelli E
    J Minim Invasive Gynecol; 2020; 27(3):583-592. PubMed ID: 31954185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy.
    Wright JD; Tergas AI; Cui R; Burke WM; Hou JY; Ananth CV; Chen L; Richards C; Neugut AI; Hershman DL
    JAMA Oncol; 2015 Apr; 1(1):69-77. PubMed ID: 26182307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.